NAT2 and CYP2E1 polymorphisms and antituberculosis drug‐induced hepatotoxicity in Peruvian patients
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NAT2
and
CYP2E1
polymorphisms and antituberculosis drug‐induced hepatotoxicity in Peruvian patients
Authors
Keywords
-
Journal
Molecular Genetics & Genomic Medicine
Volume 10, Issue 8, Pages -
Publisher
Wiley
Online
2022-06-25
DOI
10.1002/mgg3.1987
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Allelic and genotypic frequencies of NAT2 , CYP2E1 , and AADAC genes in a cohort of Peruvian tuberculosis patients
- (2021) Kelly S. Levano et al. Molecular Genetics & Genomic Medicine
- NAT2 variants and toxicity related to anti-tuberculosis agents: a systematic review and meta-analysis
- (2019) M. Richardson et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- NAT2 slow acetylator associated with anti-tuberculosis drug-induced liver injury in Thai patients
- (2016) S. Wattanapokayakit et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Factors associated with anti-TB drug-induced hepatotoxicity and genetic polymorphisms in indigenous and non-indigenous populations in Brazil
- (2016) Melissa M. Heinrich et al. TUBERCULOSIS
- NAT2 gene diversity and its evolutionary trajectory in the Americas
- (2015) R Bisso-Machado et al. PHARMACOGENOMICS JOURNAL
- Recent progress in genetic variation and risk of antituberculosis drug-induced liver injury
- (2014) Yi-Shin Huang Journal of the Chinese Medical Association
- PharmGKB summary
- (2014) Ellen M. McDonagh et al. Pharmacogenetics and Genomics
- Genetic Polymorphisms of Cytochrome P450 and Glutathione S-transferase Associated with Antituberculosis Drug-induced Hepatotoxicity in Chinese Tuberculosis Patients
- (2013) T Wang et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Meta-Analysis of Clinical Studies Supports the Pharmacokinetic Variability Hypothesis for Acquired Drug Resistance and Failure of Antituberculosis Therapy
- (2012) Jotam G. Pasipanodya et al. CLINICAL INFECTIOUS DISEASES
- Pharmacogenetic Study of Drug-Metabolising Enzyme Polymorphisms on the Risk of Anti-Tuberculosis Drug-Induced Liver Injury: A Meta-Analysis
- (2012) Yu Cai et al. PLoS One
- Multidrug resistance after inappropriate tuberculosis treatment: a meta-analysis
- (2011) Marieke J. van der Werf et al. EUROPEAN RESPIRATORY JOURNAL
- N-acetyltransferase 2 polymorphisms and risk of anti-tuberculosis drug-induced hepatotoxicity in Caucasians
- (2011) V. Leiro-Fernandez et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Risk factors of hepatitis during Anti-tuberculous treatment and implications of hepatitis virus load
- (2011) Jann-Yuan Wang et al. JOURNAL OF INFECTION
- A web server for inferring the human N-acetyltransferase-2 (NAT2) enzymatic phenotype from NAT2 genotype
- (2009) I. B. Kuznetsov et al. BIOINFORMATICS
- Genetic Polymorphism in CYP2E1: Population Distribution of CYP2E1 Activity
- (2009) Pat Neafsey et al. JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started